higher doses of tirzepatide Can you take a day early? The complete guide to dose timing Lasting success at higher doses

Key findings: Semaglutide has been linked to higher odds of depression (1.87x) and suicidal behavior (1.73x) in some reports, though clinical trials show no consistent increase in psychiatric risks

In addition, SGLT-2 inhibitors have shown benefit in patients with both HFrEF and HFpEF independently of diabetes status, which opens exciting possibilities for the use of these therapies in patients at risk for or with established CV or kidney disease without T2D

The grey market for weight-loss drugs has been booming in China, Allan Von Mehren, chief analyst and China economist at Danske Bank, told Al Jazeera

Food and Drug Administration (FDA) on the 1st approved 'Foundayo (ingredient name: orforglipron),' an oral obesity treatment developed by Eli Lilly, the company that supplies the obesity drug 'Mounjaro.' This is the second oral GLP-1 class obesity treatment to be approved, following the pill form of Novo Nordisk's 'Wegovy' last December

Because as of early 2025, semaglutide and tirzepatide were being removed from the shortage list, they are no longer legally available to be compounded